These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11221596)

  • 1. [Ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy].
    Cecchi F
    Ital Heart J Suppl; 2000 Dec; 1(12):1648-9. PubMed ID: 11221596
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Fatkin D; Graham RM
    N Engl J Med; 2001 Jan; 344(1):63-5. PubMed ID: 11187116
    [No Abstract]   [Full Text] [Related]  

  • 3. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
    Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
    Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sudden death risk factors in patients with hypertrophic cardiomyopathy].
    Dabrowski M; Borowiecka E; Michalak E; Rydlewska-Sadowska W; Ruzyłło W
    Kardiol Pol; 1989; 32(2):57-65. PubMed ID: 2482379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sudden death in hypertrophic and dilated cardiomyopathies].
    Koga Y; Kihara K; Tsubaki K
    Kokyu To Junkan; 1989 Mar; 37(3):251-6. PubMed ID: 2734502
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy].
    Spirito P; Piccininno M
    Ital Heart J Suppl; 2000 Jun; 1(6):840-1. PubMed ID: 11204022
    [No Abstract]   [Full Text] [Related]  

  • 8. The natural history of hypertrophic cardiomyopathy.
    McKenna WJ
    Cardiovasc Clin; 1988; 19(1):135-48. PubMed ID: 3048679
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiomyopathies (VII). Natural history of hypertrophic cardiomyopathy].
    Sáenz de la Calzada C; Tello de Meneses R; Delgado Jiménez J; Gómez Pajuelo C; Gómez Sánchez MA; González Cocina E
    Rev Esp Cardiol; 1996 Mar; 49(3):214-25. PubMed ID: 8685525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged QT and hypertrophic cardiomyopathy in two families with 10 sudden deaths.
    Gupta PR; Somani PN; Avasthey P; Singh VP
    J Assoc Physicians India; 1985 May; 33(5):353-5. PubMed ID: 4044501
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sudden death in hypertrophic obstructive cardiomyopathy].
    Ovodova NF
    Klin Med (Mosk); 1984 Nov; 62(11):60-2. PubMed ID: 6542956
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
    Basso C; Thiene G; Mackey-Bojack S; Frigo AC; Corrado D; Maron BJ
    Eur Heart J; 2009 Jul; 30(13):1627-34. PubMed ID: 19406869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.
    Spirito P; Bellone P; Harris KM; Bernabo P; Bruzzi P; Maron BJ
    N Engl J Med; 2000 Jun; 342(24):1778-85. PubMed ID: 10853000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
    Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
    Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertrophic cardiomyopathy. Arrhythmia in hypertrophic cardiomyopathy].
    Colín Lizalde Lde J
    Arch Cardiol Mex; 2003; 73 Suppl 1():S26-30. PubMed ID: 12966640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genetic testing in paediatric syndromes of sudden death: state of the art and future considerations.
    McCormack J
    Cardiol Young; 2009 Nov; 19 Suppl 2():54-65. PubMed ID: 19857351
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.